Blood test picks out cancers likely to benefit from targeted drugs
British researchers discovered that a blood test could identify gastric cancer patients who might benefit from EGFR-inhibiting drugs.
	For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org


Powering progress to defeat stomach cancer.


Powering progress to defeat stomach cancer.
MORE INFODONATEDONATEMORE INFO